Clinical trial
Application of Salivary and Plasma Exosomes in the Diagnosis of Oral Leukoplakia Malignant Transformation and Prognosis Monitoring of Oral Cancer
NCT06469892 is registered in ClinicalTrials.gov with Beijing Stomatological Hospital, Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Salivary and Plasma Exosomes in the Diagnosis of Oral Leukoplakia Malignant Transformation and Prognosis Monitoring of Oral Cancer
- Lead sponsor
- Beijing Stomatological Hospital, Capital Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 13, 2020
- Completion date
- July 30, 2023
- Enrollment
- 225 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral cancer, oral leukoplakia